JPRN-UMIN000003444
Completed
未知
Prospective observational study in patients with spinal and bulbar muscular atrophy (SBMA) who completed the phase 3 clinical trial of TAP-144-SR (3M) . - Prospective observational study in patients with SBMA who completed the phase 3 clinical trial of TAP-144-SR (3M).
eurology, the University of Tokyo Hospital0 sites18 target enrollmentApril 2, 2010
ConditionsSpinal and Bulbar Muscular Atrophy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Spinal and Bulbar Muscular Atrophy
- Sponsor
- eurology, the University of Tokyo Hospital
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients judged as inappropriate to this study by investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Observational study in patients undergoing gynaecological surgeries to estimate the duration of perioperative fasting and its effect on the recovery profile.CTRI/2024/05/067885Other
Recruiting
Not Applicable
A prospective observational study in patients with chronic liver disease by magnetic resonance elastographyChronic liver diseaseJPRN-UMIN000045236Musashino Red Cross Hospital1,000
Recruiting
Not Applicable
CT PReoperative planning and Outcome after myectomy in patients with Hypertrophic CardioMyopathy: Prospective observational studyDiseases of the circulatory systemKCT0008703Asan Medical Center100
Recruiting
Not Applicable
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
Completed
Not Applicable
A prospective observational study of patients with advanced cancer for the evaluation of checkpoint inhibitor-associated cardiovascular immune-related adverse eventsAdvanced non-small-cell lung cancer and advanced gastric cancer which are indications for anti-cytotoxic T-lymphocyte-associated antigen-4, anti-programmed death-1, and anti-programmed death-ligand 1 antibodies.JPRN-UMIN000032729Frontline Immunotherapy Team, Sendai Kousei Hospital129